Computational Systems Biology Services

Computational power for pharmaceutical research and life sciences

Our experts at Bayer Technology Services (BTS) efficiently execute application projects in pharmaceutical research and life sciences using our unique software platform and our broad experience gained in more than 100 application projects. 

We usually divide an application project into three phases. During the first phase, customer data is integrated with publicly available information and a mechanistic model is established. In case of physiologically based pharmacokinetic models, this process is highly standardized as physiological information and the core model is created by means of PK-Sim. In case of signaling pathways and networks modeling, however, this phase is more or less work intensive, depending on the specific task.

During the second phase, the established model is applied for the simulation of scenarios that are of interest customized to the current stage of a development project. During the third phase, the established model is utilized along the customer's whole development project by integrating newly available information and simulating scenarios that then become relevant. The established models can also be applied for all backup candidates and for all succeeding development projects in a specific indication.

Project areas include but are not limited to:

Drug Discovery Support

  • Target Identification & Validation
  • Biomarker Analysis
  • Proof-of-Mechanism

Drug Development Support

  • Species Extrapolation (e.g. first in man)
  • Extrapolation to Special Populations (e.g. pediatrics or impairment)
  • Proof-of-Concept
  • Bioequivalence Studies

 

 

Quicksearch Quicksearch

December 12, 2011

Published: Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, Part 2: Extension to describe performance of solid dosage forms.

» More

October 20, 2011

Published in Nature: Few inputs can reprogram biological networks

» More

October 14, 2011

Published: Quantifying stability in gene list ranking across microarray derived clinical biomarkers

» More

January 25, 2012

33rd EORTC PAMM Winter Meeting (Pharmacology and Molecular Mechanisms Group of the European Organisation for Research and Treatment of Cancer), Jan 25-28, Puerto de la Cruz, Tenerife, Spain

» More

February 08, 2012

5th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD), February 8-11, Barcelona, Spain

» More

March 12, 2012

2012 ASCPT Annual Meeting, March 12-17, National Harbor, MD, USA

» More